Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations

NCT04688008 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability Study

Interventions

DRUG: Hetrombopag

Sponsor

Jiangsu HengRui Medicine Co., Ltd.